impt-314
·Code: IMPT-314
impt-314: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Lyell Immunopharma, Inc. (LYEL) | Phase 2 |
Get deeper analysis on impt-314
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis